Sunday, June 8, 2008

Best Delivery Buy ...!!! June 9th 2008...Marksans Pharma (524404) (cmp Rs 22.10)

(Click the above chart to enlarge)
Notable Observes
  1. Marksans was incorporated in 2001 as a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. and later spun-off into a separate entity - Glenmark Laboratories Ltd. ("GLL") in March 2003 subsequently changed its name to "Marksans Pharma Ltd" in 2005.
  2. Marksans Pharma is vertically integrated global player with strong presence across the entire value chain from Active Pharmaceuticals Ingredient's (APIs) to formulations to biopharmaceuticals.
  3. Marksans Pharma is engaged in R&D and offers Contract Research and Manufacturing Services (CRAMS) to global pharmaceuti cal companies.
  4. The specialty focus of Marksans Pharma traverses through a wide array of prescription drugs. These drugs have markets spanning the medical fields of Oncology, Gastroenterology, Antidiabetic, Cardiovascular, Pain Management, Gynaecology and others. Furthermore, Marksans also inroads into complex and intricate markets dealing with Biotechnology and Neuro-psychiatry.
  5. The R&D capabilities of the Company include chemical synthesis and process optimization, formulation development and specialized drug delivery systems.
  6. Plants are built as per US FDA guidelines and approved by venerated UK MHRA, Australia TGA and Brazilian ANVISA health authorities.

Share holding pattern

  • Promoter : 50.02%
  • Public : 49.98%

Financial Highlights

  • Net Sales of Rs. 242.961 Crore for year ending on 31-MAR-2008 against Rs. 240.787 crore for the last year.
  • Net Profit of Rs. 17.412 Crore for the year ending on 31-MAR-2008 against Rs. 9.904 crore for the last year.

Technical Overview

The stock has witnessed huge volumes for last three weeks. On daily chart the stock has formed "Inverted Head & Shoulder Pattern" ( Refer to chart above ), indicating a fresh up move for the stock. The stock is recommend to buy at the Cmp 22.10.

Support

  • Support 1 : 20
  • Support 2 : 18.50

Stop Loss : 17 on closing basis

Targets

  • Target 1 : 28
  • Target 2 : 30
  • Target 3 : 34

Period : 3 to 4 months.

No comments: